Human immunodeficiency virus reverse transcriptase and protease sequence database
By Soo-Yon Rhee, M. J. Gonzales, R. Kantor, B. Betts, Jaideep Ravela, R. Shafer. Nucleic Acids Res., 2003
1,044 citations recorded by the source corpus.
Subfields: Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/fa3c3fb3db6d54105c7990b6fd3ef41f3aff439d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
In Virology
Citations in the corpus
- Selecting anti-HIV therapies based on a variety of genomic and clinical factors (2008, methodology): “This approach is frequently applied and termed Genotypic Susceptibility Score (GSS; Rhee et al., 2003) In Figure 4 theAUC curves of engines trained with a minimal and maximal set of features are provided.”
- Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level (2002, background): “observed that external residues have the most polymorphism between viral isolates.(152,155,156) Within the bounds of this fundamental constraint, the presence or”
- Predicting the effects of amino acid substitutions on protein function. (2006, background): “Popular nonneutral sets include data from laboratory mutagenesis experiments (36, 49, 54, 80), human disease proteins where many mutations have been characterized (3, 21, 22, 25, 32, 50, 55, 70), and human disease databases such as OMIM, HGMD, or SwissProt (1, 24, 62), which contain AASs that have b”
- An automated genotyping system for analysis of HIV-1 and other microbial sequences (2005, methodology): “In the setting of HIV-1, these software tools include methods for the detection of drug-induced resistance mutations (Shafer et al., 1999), the identification of immunodominant epitopes for inclusion in an AIDS vaccine (Korber et al., 2002) and, more recently, the development of an integrated…”
- A SIGNIFICANCE TEST FOR THE LASSO (2013, background): “Rhee et al. (2003) study six nucleotide reverse transcriptase inhibitors (NRTIs) that are used to treat HIV-1.”